When the government of Peru authorized ivermectin for use during the COVID-19 pandemic, a natural experiment occurred that provided evidence of the drug’s effectiveness, according to a new peer-reviewed ecological study,
The paper’s results, published Aug. 8 in Cureus, found a 74 percent reduction in excess deaths in 10 states with the most intensive ivermectin use over a 30-day period following peak deaths during the pandemic. When analyzing data across 25 states in Peru, researchers found that these reductions in excess deaths correlated closely to ivermectin use during four months in 2020.
